Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Gross Profit (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 2 years of Gross Profit data on record, last reported at $1.9 million in Q3 2025.

  • For Q3 2025, Gross Profit rose 51.78% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $3.5 million, changed N/A, while the annual FY2024 figure was $2.3 million, 23.06% down from the prior year.
  • Gross Profit reached $1.9 million in Q3 2025 per TNXP's latest filing, up from -$1.3 million in the prior quarter.
  • Across five years, Gross Profit topped out at $1.9 million in Q3 2025 and bottomed at -$1.3 million in Q2 2025.